BMY Trading Analysis - 09/11/2026 05:13 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for BMY include:

• Bristol Myers Squibb (BMY) announces FDA approval for a new therapy.
• BMY reports strong quarterly earnings, beating analyst expectations.
• The company announces a strategic partnership with a biotech firm.

These headlines suggest positive developments for BMY, which could impact the stock's performance. However, the technical and sentiment analysis will provide a more comprehensive view.

Fundamental Analysis:

Based on the provided fundamentals data:

• Revenue: $49.19 billion
• Trailing EPS: $4.54
• Trailing P/E: 14.04
• Price-to-Book: 11.67
• Debt-to-Equity: 1.92
• Return on Equity (ROE): 41.55%

The company's fundamentals indicate a stable revenue base, with a trailing EPS of $4.54 and a P/E ratio of 14.04, suggesting a relatively fair valuation. However, the high debt-to-equity ratio of 1.92 may be a concern.

Current Market Position:

Current price: $63.64

Recent price action: The stock has been trending downward, with a recent low of $63.27 and a high of $64.20.

Intraday momentum: The minute bars show a slight increase in price with moderate volume.

Technical Analysis:

SMA trends:

• 5-day SMA: $64.66
• 20-day SMA: $66.18
• 50-day SMA: $63.43

The stock is currently below its 5-day, 20-day, and 50-day SMAs, indicating a bearish trend. The RSI of 29.48 suggests the stock is oversold, which could lead to a rebound. The MACD is positive, indicating potential for upward momentum.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Balanced

Call vs Put dollar volume:

• Call dollar volume: $680,513
• Put dollar volume: $639,117

The options flow sentiment is balanced, with a slight bias towards calls. This suggests that traders are not strongly bullish or bearish on the stock.

Key Price Levels:

Key support level: $63.27 (recent low)

Key resistance level: $64.69 (recent high)

25-Day Price Forecast:

Based on current technical trends, momentum, and indicators, BMY is projected for $62.50 to $65.00.

This range is based on the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).

Defined Risk Strategy Recommendations:

Based on the price forecast, here are three defined risk strategy recommendations:

1. Buy Call Spread with a strike price of $63.50 and an expiration date of 2026-10-16.
2. Buy Bear Put Spread with a strike price of $62.00 and an expiration date of 2026-10-16.
3. Sell Iron Condor with strike prices of $61.00, $63.00, $65.00, and $67.00, and an expiration date of 2026-10-16.

These strategies align with the projected price range and offer defined risk.

Risk Factors:

Technical warning signs:

• Breakdown below $63.27 could indicate further downside.

Sentiment divergences:

• A shift in options flow sentiment could impact the stock price.

Volatility and ATR considerations:

• High volatility could impact the performance of the recommended strategies.

Summary & Conviction Level:

Overall bias: Neutral

Conviction level: Medium

One-line trade idea: Consider defined risk strategies based on the projected price range.